|
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study |
|
|
|
Titel: |
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study |
Auteur: |
Fan, Xiaohong Dai, Xiahong Ling, Yun Wu, Lihua Tang, Lingling Peng, Chunxian Huang, Chaolin Liu, Hongyan Lu, Hongzhou Shen, Xinghua Zhang, Wei Wang, Furong Li, Guangming Li, Ming Huang, Yanming Zhang, Hongying Li, Minghui Ren, Fei Li, Yuanyuan Liu, Chenfan Zhou, Zhiguo Sun, Wei Yi, Yongxiang Zhou, Daming Gao, Hainv Pan, Qi Liu, Hongde Zhao, Jiang Ding, Zhen Ma, Yingmin Li, Wei Wang, Quanhong Wang, Xicheng Bai, Yichun Jiang, Xiangao Ma, Juan Xie, Bingying Zhang, Kui Li, Lanjuan |
Verschenen in: |
The lancet infectious diseases |
Paginering: |
Jaargang 24 () nr. 2 pagina's 129-139 |
Jaar: |
2024 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|